Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 15Squamous Cell Carcinoma of Head and Neck 2Lung Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Resectable Non-small Cell Lung Cancer 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Nonsquamous Non-small Cell Lung Cancer 1Non-Squamous Non-Small Cell Lung Cancer 1Neoplasm Metastasis 1Melanoma 1Head and Neck Neoplasms 1Glioma 1Carcinoma, Renal Cell 1Advanced Non-small Cell Lung Cancer 1

Interventions

Paclitaxel 2Cisplatin 2Carboplatin 2cemiplimab 1Platinum Compounds 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Resectable Non-small Cell Lung Cancer × Platinum Compounds × Clear all
NCT06169956 2024-04-18

NENI

Bristol-Myers Squibb

Recruiting
400 enrolled
Thoracic

Resectable Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡